OR WAIT null SECS
August 29, 2014
The National Institute of Allergy and Infectious Diseases will begin the first in a series of trials for an Ebola vaccine during the week of Sept. 1.
August 15, 2014
Concerns about quality in overseas production may bring generic drug production back to the United States, concludes CPhI study.
August 07, 2014
The European system for assessing drugs will be used as a model internationally.
August 04, 2014
EMA has released the second module of a new guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of a module on the quality requirements.
August 02, 2014
Customers are looking to reduce risk, increase performance, and optimize productivity.
FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.
Experts from Capsugel and Catalent discuss the rationale of using lipid0basd formulations to improve the oral bioavailability of poorly soluble drugs.
August 01, 2014
New chemical entities with poor aqueous solubility require the use of technologies to enable sufficient oral bioavailability of these NCEs following administration.
With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars.
Experts discuss developments and future trends in prefilled syringes.
